Display search results for ** instead (360 products)

Showing 1-10 of 360

03 Jun 2004  |  Global

UCB - Celltech Merger - A Strategic Snapshot

 

The white paper, The UCB-Celltech Merger  A Strategic Snapshot, includes the details of the merger, stock analysis, and product pipeline analysis of Celltech. The white paper includes analysis of Celltech's lead product CDP-870 and its market potential, rheumatoid arthritis and Crohns disease market overview, competitive analysis of biologics for...

USD 1,800.00

USD 1,350.00 save 25 %

Globally, nations are experiencing a decline in population growth rate accompanied by fall in mortality rate, increase in life expectancy and improvement in health condition. However, these trends have resulted in an increase in percent of aged people in the total population or an Aging Society. The segment gives an overview of the common demogra...

USD 1,500.00

USD 1,125.00 save 25 %

Expiring patents on revenue generating drugs, competition from generic drugs and increasing research and development cost, is forcing pharmaceutical manufacturers to often outsource drug discovery processes. Over the years pharmaceutical outsourcing has moved up the value chain from non core functions to even core functions. The segment gives an ov...

USD 1,500.00

USD 1,125.00 save 25 %

Though most countries were affected by the current economic slowdown, the impact varied from country to country. The article looks into the affect of slowdown in six emerging countries, namely Brazil, Russia, China, India, Mexico and Poland and covers the highlights of economic stimulus measures adopted by these countries. The article also provides...

USD 1,500.00

USD 1,125.00 save 25 %

The global economic slowdown affected almost every nation across the globe, though, the impact varied from country to country. The article discusses the healthcare system, current healthcare related issues and recent health sector initiatives in five developed nations, namely the United States, Japan, Germany, France and United Kingdom. In addition...

USD 1,500.00

USD 1,125.00 save 25 %

 

USD 1,500.00

USD 1,125.00 save 25 %

 

USD 1,500.00

USD 1,125.00 save 25 %

 

USD 1,500.00

USD 1,125.00 save 25 %

Japan is emerging as a force to reckon with in the global biotechnology landscape. Lately, committed support from the government and resulting administrative changes have brought the Japanese biotech industry to an inflection point. There are plenty of opportunities for Japanese biotech companies to explore and fewer hurdles on their path compared ...

USD 1,500.00

USD 1,125.00 save 25 %

South Korean biotechnology industry is poised to become an important biotechnology hub in Asia Pacific region. Strong government support, well developed infrastructure, and increasing scientific pool have created a positive environment for growth of industry. The private sector too has realized the growing importance of participation. Many biotech ...

USD 1,500.00

USD 1,125.00 save 25 %

Showing 1-10 of 360